Minimal change disease as a modifiable podocyte paracrine disorder.
about
Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1Protective effects of low-dose rapamycin combined with valsartan on podocytes of diabetic rats.Proteinuria predicts relapse in adolescent and adult minimal change disease.Childhood nephrotic syndrome--current and future therapies.Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.The glomerular filtration barrier: components and crosstalkTacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome.Morphological study of progressive glomerulonephropathy in common marmosets (Callithrix jacchus).
P2860
Q34044253-E7F80128-92DB-485E-BA8E-25537B3DEF24Q36183003-8994A140-215E-4B1B-993A-91C9B9A7E915Q36371221-F4A559A1-BBBD-468F-8B35-283C4E65A7CCQ38017937-AF50252F-BF16-42E0-8EC5-C62C3E800786Q38026511-BBC4D75D-3D3A-4473-87FC-B95408B226ABQ38039100-75C0C64E-6F4D-462E-8DA1-21FD750FA6F2Q48749887-6083FF32-CFBD-4498-94BA-5EB489028A43Q50494509-30902D80-57B4-46CE-AE13-D2ED97A80374
P2860
Minimal change disease as a modifiable podocyte paracrine disorder.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Minimal change disease as a modifiable podocyte paracrine disorder.
@ast
Minimal change disease as a modifiable podocyte paracrine disorder.
@en
type
label
Minimal change disease as a modifiable podocyte paracrine disorder.
@ast
Minimal change disease as a modifiable podocyte paracrine disorder.
@en
prefLabel
Minimal change disease as a modifiable podocyte paracrine disorder.
@ast
Minimal change disease as a modifiable podocyte paracrine disorder.
@en
P2860
P356
P1476
Minimal change disease as a modifiable podocyte paracrine disorder.
@en
P2093
Changli Wei
Jochen Reiser
P2860
P304
P356
10.1093/NDT/GFR124
P407
P577
2011-03-17T00:00:00Z